MAGNOSCO
Magnosco is a company focused on early-stage skin cancer detection. Magnosco develops a method for early stage malignant melanoma detection, known as dermatofluoroscopy. The non-invasive diagnostics are based on infrared laser and artificial intelligence technology.
MAGNOSCO
Industry:
Biotechnology Health Care Medical Medical Device
Founded:
2014-01-01
Address:
Berlin, Berlin, Germany
Country:
Germany
Website Url:
http://www.en.magnosco.com
Total Employee:
1+
Status:
Active
Contact:
+49 (0)30 912075 357
Total Funding:
0
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SSL By Default Apple Mobile Web Clips Icon Content Delivery Network Euro Google GStatic Google Static Content Google Cloud Sectigo SSL
Similar Organizations
Calimmune
Calimmune is a clinical-stage gene therapy company.
Dermavant Sciences
Dermavant Sciences is a biotechnology company focused on dermatology.
Oncose
Oncose is an emerging market leader in cancer detection.
Current Advisors List
Current Employees Featured
Founder
Investors List
SPRIM Ventures
SPRIM Ventures investment in Venture Round - Magnosco
Corecam Family Office
Corecam Family Office investment in Venture Round - Magnosco
More informations about "Magnosco"
Magnosco
Magnosco is a Berlin-based company founded in 2014. We have always worked on solutions for dermatology and our team of scientists and developers has a lot of experience in the field of medical technology. By working closely with โฆSee details»
Magnosco
Since 2014, Magnosco has been researching new methods for skin cancer diagnostics at the Berlin-Adlershof Science and Technology Park. Our goal is to improve the quality of skin health by using the latest results from optics, AI, โฆSee details»
Magnosco - Crunchbase Company Profile & Funding
Magnosco is a company focused on early-stage skin cancer detection. Magnosco develops a method for early stage malignant melanoma detection, known as dermatofluoroscopy. The โฆSee details»
Magnosco
Mit der Produktlandschaft vom Magnosco sind Sie auf dem richtigen Weg in die Digitalisierung und Ihre Patienten werden Ihren innovativen Weg zu schätzen wissen. Abgerundet wird โฆSee details»
Magnosco (Diagnostic Equipment) - PitchBook
Mar 11, 2020 Magnosco (Diagnostic Equipment) was acquired on 01-Jul-2022. Who acquired Magnosco (Diagnostic Equipment)? Magnosco (Diagnostic Equipment) was acquired by Ltb โฆSee details»
Magnosco - Funding, Financials, Valuation & Investors - Crunchbase
Mar 11, 2020 How much funding has this organization raised over time? Show . Announced Date . Transaction Name . Number of Investors . Money Raised . Lead Investors . Mar 11, โฆSee details»
Magnosco GmbH Company Profile - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for Magnosco GmbH of Berlin, Berlin. Get the latest business insights from Dun & Bradstreet.See details»
Magnosco - Contacts, Employees, Board Members, Advisors
Magnosco is a company focused on early-stage skin cancer detection. New. Resources. Advanced Search. Start Free Trial . Talk With Sales. Pricing. Log In. Log In. Experience the โฆSee details»
Magnosco GmbH - Drug pipelines, Patents, Clinical trials - Synapse
Explore Magnosco GmbH with its drug pipeline, therapeutic area, technology platform, 1 clinical trial, and 6 literature. Explore Magnosco GmbH with its drug pipeline, therapeutic area, โฆSee details»
Magnosco
Working at Magnosco is demanding because everyday tasks are characterized by a high degree of complexity. On the other hand, itโs a fantastic feeling to work with brilliant colleagues on โฆSee details»
WILDDESIGN | Magnosco - Magnos
Magnosco. Magnos - An AI-supported digital dermoscopy system. By 2040, researchers from the International Agency for Research on Cancer (IARC) predict an increase in annual skin โฆSee details»
News 2 - Magnosco
Magnosco has existed as a company since 2014 and has been able to look back on a broad circle of investors to date. After several rounds of financing, we are now proud to report that we have โฆSee details»
Magnosco Company Information - Funding, Investors, and More
Get information on funding, investors, industries, and more for Magnosco. See Magnosco company profile and funding data.See details»
Thomas Diepold - CFO & Managing Director @ Magnosco
Primary Organization . Magnosco . Location Berlin, Berlin, Germany; Regions European Union (EU), Europe, Middle East, and Africa (EMEA) Gender Male; LinkedIn View on LinkedIn ; โฆSee details»
What is Magnosco? Company Culture, Mission, Values
See what employees say it's like to work at Magnosco. Salaries, reviews, and more - all posted by employees working at Magnosco.See details»
Magnosco
This basic academic research was decisive and fundamental for Magnoscoโs path. Founding As early as 2010, Dr. Hans-Georg Giering, who would later become the founder of Magnosco, โฆSee details»
API Organization Verification | OpenAI Help Center
You must not have recently verified another organization, as each ID can only verify one organization every 90 days. Please note, not all organizations will be eligible for verification. โฆSee details»
Medical product development - magnosco.com
Dermatofluoroscopy is a method for the early detection of malignant melanoma. This patented technology is based on the selective excitation of melanin fluorescence in the skin. The skin โฆSee details»
Magnosco
Quality is paramount in the medical sector. But it goes without saying that we also strive to deliver the best possible quality to our customers.See details»
Magnosco
Includes relevant news and updates related to Magnosco and skin diagnostics.See details»